{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:10:10Z","timestamp":1778479810701,"version":"3.51.4"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The causal effect of lower plasma sclerostin on cardiovascular disease (CVD) risk has previously been examined with the aim of investigating potential side effects of pharmacological sclerostin inhibition for treatment of osteoporosis. We explored the relationship between plasma sclerostin levels and CVDs and bone phenotypes using Mendelian randomization (MR) and correlation between plasma sclerostin levels and these outcomes. We used variants identified in genome-wide association studies of plasma sclerostin levels in large proteomic datasets from the UK Biobank (Olink) and Iceland (SomaScan) as instruments in two separate MR analyses. These analyses did not provide evidence of association between the effects of sequence variants on plasma sclerostin levels and their effects on CVDs and CVD risk factors (P\u2009&amp;gt;\u20090.05). Several of the instruments had heterogenic effects on bone phenotypes and causal estimates in MR were non-significant (P\u2009&amp;gt;\u20090.05\/8). Plasma sclerostin levels correlated positively with coronary artery disease, myocardial infarction and CVD risk factors. Our results do not provide evidence supporting the hypothesis that lower plasma sclerostin levels increase CVD risk and suggest that plasma sclerostin levels are not a good surrogate for pharmacological inhibition.<\/jats:p>","DOI":"10.1093\/hmg\/ddaf177","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T12:31:17Z","timestamp":1763382677000},"source":"Crossref","is-referenced-by-count":0,"title":["Observational and Mendelian randomization studies of plasma sclerostin levels do not provide evidence of cardiovascular adverse effects of sclerostin inhibition"],"prefix":"10.1093","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7475-0398","authenticated-orcid":false,"given":"Rosa B","family":"Thorolfsdottir","sequence":"first","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gardar","family":"Sveinbjornsson","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grimur","family":"Hjorleifsson Eldjarn","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hildur M","family":"Aegisdottir","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]},{"name":"Faculty of Medicine, School of Health Sciences, University of Iceland , Vatnsmyrarvegur 16, 101 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unnur","family":"Styrkarsdottir","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solveig","family":"Gretarsdottir","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valgerdur","family":"Steinthorsdottir","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicius","family":"Tragante","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmundur","family":"Oddsson","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilja","family":"Stefansdottir","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudmar","family":"Thorleifsson","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudmundur","family":"Einarsson","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannes","family":"Helgason","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]},{"name":"School of Engineering and Natural Sciences , University of Iceland, Saemundargata 2, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea B","family":"Jonsdottir","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]},{"name":"Faculty of Medicine, School of Health Sciences, University of Iceland , Vatnsmyrarvegur 16, 101 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigurjon A","family":"Gudjonsson","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egil","family":"Ferkingstad","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0316-5866","authenticated-orcid":false,"given":"S\u00f8ren","family":"Brunak","sequence":"additional","affiliation":[{"name":"Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3B, 2200 Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanna","family":"Br\u00f8ns","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet , Blegdamsvej 9, 2100 Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan S","family":"Bundgaard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital, Rigshospitalet , Blegdamsvej 9, 2100 Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mie T","family":"Bruun","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Odense University Hospital , J. B. Winsl\u00f8ws Vej 4, 5000 Odense ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6551-6647","authenticated-orcid":false,"given":"Christian","family":"Erikstrup","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Aarhus University Hospital , Palle Juul-Jensens Boulevard 99, 8200 Aarhus ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Aarhus University , Aarhus, Palle H. Kristensens Vej 7, 8200 \u00a0","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bitten","family":"Aagaard","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Aalborg University Hospital , Urbansgade 32-36, 9000 Aalborg ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole B","family":"Vesterager Pedersen","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Zealand University Hospital , Lykkeb\u00e6kvej 1, 4600 K\u00f8ge ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3B, 2200 Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirstine L","family":"Sibilitz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amager and Hvidovre University Hospital , Ketteg\u00e5rd All\u00e9 30, 2650 Hvidovre Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet , Blegdamsvej 9, 2100 Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Tr\u00e6holt","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet , Blegdamsvej 9, 2100 Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7306-9058","authenticated-orcid":false,"given":"Henrik","family":"Ullum","sequence":"additional","affiliation":[{"name":"Statens Serum Institut , Artillerivej 5, 2300 Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoqun","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital, Rigshospitalet , Blegdamsvej 9, 2100 Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-4130","authenticated-orcid":false,"given":"Kirk U","family":"Knowlton","sequence":"additional","affiliation":[{"name":"Intermountain Medical Center, Intermountain Heart Institute , 5121 South Cottonwood Street, Murray, UT 84107 ,","place":["United States"]},{"name":"School of Medicine, University of Utah , 30 N 1900 E, Salt Lake City, UT 84132 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lincoln D","family":"Nadauld","sequence":"additional","affiliation":[{"name":"Precision Genomics, Intermountain Healthcare , 600 S Medical Center Dr, Saint George, UT 84790 ,","place":["United States"]},{"name":"School of Medicine, Stanford University , Stanford, 291 Campus Drive, Li Ka Shing Building, CA 94305\u20115101 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisse R","family":"Ostrowski","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet , Blegdamsvej 9, 2100 Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3B, 2200 Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0563-7049","authenticated-orcid":false,"given":"Henning","family":"Bundgaard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital, Rigshospitalet , Blegdamsvej 9, 2100 Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3B, 2200 Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David O","family":"Arnar","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]},{"name":"Faculty of Medicine, School of Health Sciences, University of Iceland , Vatnsmyrarvegur 16, 101 Reykjavik ,","place":["Iceland"]},{"name":"Department of Cardiology, Landspitali, The National University Hospital of Iceland , Hringbraut, 101 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingileif","family":"Jonsdottir","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]},{"name":"Faculty of Medicine, School of Health Sciences, University of Iceland , Vatnsmyrarvegur 16, 101 Reykjavik ,","place":["Iceland"]},{"name":"Department of Immunology, Landspitali, The National University Hospital of Iceland , Hringbraut, 101 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1806-2467","authenticated-orcid":false,"given":"Anna","family":"Helgadottir","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unnur","family":"Thorsteinsdottir","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]},{"name":"Faculty of Medicine, School of Health Sciences, University of Iceland , Vatnsmyrarvegur 16, 101 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilma","family":"Holm","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Sulem","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F","family":"Gudbjartsson","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]},{"name":"School of Engineering and Natural Sciences , University of Iceland, Saemundargata 2, 102 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1676-864X","authenticated-orcid":false,"given":"Kari","family":"Stefansson","sequence":"additional","affiliation":[{"name":"Amgen deCODE Genetics , Sturlugata 8, 102 Reykjavik ,","place":["Iceland"]},{"name":"Faculty of Medicine, School of Health Sciences, University of Iceland , Vatnsmyrarvegur 16, 101 Reykjavik ,","place":["Iceland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"DBDS Genomic Consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"2026051101314596000_ref1","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"key":"2026051101314596000_ref2","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"},{"key":"2026051101314596000_ref3","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1210\/jc.2017-02163","article-title":"A phase III randomized placebo-controlled trial to evaluate efficacy and safety of Romosozumab in men with osteoporosis","volume":"103","author":"Michael Lewiecki","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026051101314596000_ref4","doi-asserted-by":"publisher","first-page":"25900","DOI":"10.1371\/journal.pone.0025900","article-title":"Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway","volume":"6","author":"Wijenayaka","year":"2011","journal-title":"PLoS One"},{"key":"2026051101314596000_ref5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet"},{"key":"2026051101314596000_ref6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia Sclerosteosis results from loss of the SOST gene product, a novel cystine knot\u2013containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2026051101314596000_ref7","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1101\/gr.3437105","article-title":"Genomic deletion of a long-range bone enhancer misregulates sclerostin in van Buchem disease","volume":"15","author":"Loots","year":"2005","journal-title":"Genome Res"},{"key":"2026051101314596000_ref8","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","article-title":"Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation","volume":"19","author":"Poole","year":"2005","journal-title":"FASEB J"},{"key":"2026051101314596000_ref9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay6570","article-title":"Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics","volume":"12","author":"Bovijn","year":"2020","journal-title":"Sci Transl Med"},{"key":"2026051101314596000_ref10","doi-asserted-by":"publisher","first-page":"E187","DOI":"10.1161\/ATVBAHA.122.317635","article-title":"Role of sclerostin in cardiovascular disease","volume":"42","author":"Golledge","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026051101314596000_ref11","volume-title":"Silver Spring, Maryland, United States. U.S. Food and Drug Administration FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture. FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture."},{"key":"2026051101314596000_ref12","volume-title":"Evenity, INN-romosozumab","author":"European Medicines Agency (EMA)"},{"key":"2026051101314596000_ref13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/13697137.2017.1289659","article-title":"The quest for new drugs to prevent osteoporosis-related fractures","volume":"20","author":"Villiers","year":"2017","journal-title":"Climacteric"},{"key":"2026051101314596000_ref14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jbmr.4467","article-title":"Circulating sclerostin levels are positively related to coronary artery disease severity and related risk factors","volume":"37","author":"Frysz","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2026051101314596000_ref15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1210\/jc.2011-2152","article-title":"Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults","volume":"97","author":"Amrein","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026051101314596000_ref16","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/art.42538","article-title":"Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: evidence from a genome-wide association meta-analysis followed by mendelian randomization","volume":"75","author":"Zheng","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2026051101314596000_ref17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","article-title":"Guidelines for performing mendelian randomization investigations: update for summer 2023","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res"},{"key":"2026051101314596000_ref18","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/art.42751","article-title":"Genetic data do not provide evidence that lower sclerostin is associated with increased risk of atherosclerosis: comment on the article by Zheng et\u00a0al","volume":"77","author":"Staley","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2026051101314596000_ref19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe8497","article-title":"Comment on \u201cevaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics\u201d","volume":"13","author":"H\u00f3lm","year":"2021","journal-title":"Sci Transl Med"},{"key":"2026051101314596000_ref20","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/jbmr.3803","article-title":"Mendelian randomization analysis reveals a causal influence of circulating sclerostin levels on bone mineral density and fractures","volume":"34","author":"Zheng","year":"2019","journal-title":"J Bone Miner Res"},{"key":"2026051101314596000_ref21","first-page":"2897","article-title":"Elevated circulating sclerostin concentrations in individuals with high bone mass, with and without LRP5 mutations","volume":"99","author":"Gregson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026051101314596000_ref22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41588-018-0302-x","article-title":"An atlas of genetic influences on osteoporosis in humans and mice","volume":"51","author":"Morris","year":"2019","journal-title":"Nat Genet"},{"key":"2026051101314596000_ref23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.bone.2011.11.016","article-title":"TGF-\u03b2 regulates sclerostin expression via the ECR5 enhancer","volume":"50","author":"Loots","year":"2012","journal-title":"Bone"},{"key":"2026051101314596000_ref24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jsbmb.2015.12.006","article-title":"Early response of the human SOST gene to stimulation by 1\u03b1,25-dihydroxyvitamin D3","volume":"164","author":"Wijenayaka","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026051101314596000_ref25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"2026051101314596000_ref26","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1056\/NEJMoa1508419","article-title":"Variant ASGR1 associated with a reduced risk of coronary artery disease","volume":"374","author":"Nioi","year":"2016","journal-title":"N Engl J Med"},{"key":"2026051101314596000_ref27","doi-asserted-by":"publisher","first-page":"00049","DOI":"10.1183\/23120541.00049-2021","article-title":"Pleiotropic associations of heterozygosity for the SERPINA1 Z allele in the UK biobank","volume":"7","author":"Fawcett","year":"2021","journal-title":"ERJ Open Res"},{"key":"2026051101314596000_ref28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/qjmed\/89.11.807","article-title":"New insights into the structural basis of \u03b11,-antitrypsin deficiency","volume":"89","author":"Lomas","year":"1996","journal-title":"QJM-Int J Med"},{"key":"2026051101314596000_ref29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","article-title":"Large-scale plasma proteomics comparisons through genetics and disease associations","volume":"622","author":"Eldjarn","year":"2023","journal-title":"Nature"},{"key":"2026051101314596000_ref30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"2026051101314596000_ref31","doi-asserted-by":"publisher","first-page":"9832","DOI":"10.1038\/s41467-024-53623-5","article-title":"Effect of genetically predicted sclerostin on cardiovascular biomarkers, risk factors, and disease outcomes","volume":"15","author":"Alcalde-Herraiz","year":"2024","journal-title":"Nat Commun"},{"key":"2026051101314596000_ref32","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.ajhg.2025.04.010","article-title":"A flexible machine learning mendelian randomization estimator applied to predict the safety and efficacy of sclerostin inhibition","volume":"112","author":"Legault","year":"2025","journal-title":"Am J Hum Genet"},{"key":"2026051101314596000_ref33","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/jbmr.4287","article-title":"Sclerostin downregulation globally by naturally occurring genetic variants, or locally in atherosclerotic plaques, does not associate with cardiovascular events in humans","volume":"36","author":"Holdsworth","year":"2021","journal-title":"J Bone Miner Res"},{"key":"2026051101314596000_ref34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/ng.3300","article-title":"The impact of low-frequency and rare variants on lipid levels","volume":"47","author":"Surakka","year":"2015","journal-title":"Nat Genet"},{"key":"2026051101314596000_ref35","first-page":"2499","article-title":"Lipid-related markers and cardiovascular disease prediction","volume":"307","author":"Di Angelantonio","year":"2012","journal-title":"JAMA"},{"key":"2026051101314596000_ref36","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"2026051101314596000_ref37","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1056\/NEJMoa0706728","article-title":"Polymorphisms associated with cholesterol and risk of cardiovascular events","volume":"358","author":"Kathiresan","year":"2008","journal-title":"N Engl J Med"},{"key":"2026051101314596000_ref38","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.jacc.2015.02.020","article-title":"Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 \u00d7 2 factorial mendelian randomization study","volume":"65","author":"Ference","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026051101314596000_ref39","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1002\/jbmr.474","article-title":"Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover","volume":"26","author":"Van Lierop","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2026051101314596000_ref40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1034\/j.1399-0004.2003.00036.x","article-title":"The natural history of sclerosteosis","volume":"63","author":"Hamersma","year":"2003","journal-title":"Clin Genet"},{"key":"2026051101314596000_ref41","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/jbmr.1794","article-title":"Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers","volume":"28","author":"Van Lierop","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2026051101314596000_ref42","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"2026051101314596000_ref43","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.nbt.2011.11.016","article-title":"Advances in human proteomics at high scale with the SOMAscan proteomics platform","volume":"29","author":"Gold","year":"2012","journal-title":"New Biotechnol"},{"key":"2026051101314596000_ref44","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease","volume":"53","author":"Ferkingstad","year":"2021","journal-title":"Nat Genet"},{"key":"2026051101314596000_ref45","doi-asserted-by":"crossref","first-page":"n2233","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"key":"2026051101314596000_ref46","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/ng.3190","article-title":"Efficient Bayesian mixed model analysis increases association power in large cohorts","volume":"47","author":"Loh","year":"2015","journal-title":"Nat Genet"},{"key":"2026051101314596000_ref47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ng.3211","article-title":"LD score regression distinguishes confounding from polygenicity in genome-wide association studies","volume":"47","author":"Bulik-Sullivan","year":"2015","journal-title":"Nat Genet"},{"key":"2026051101314596000_ref48","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"2026051101314596000_ref49","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.3406","article-title":"An atlas of genetic correlations across human diseases and traits","volume":"47","author":"Bulik-Sullivan","year":"2015","journal-title":"Nat Genet"},{"key":"2026051101314596000_ref50","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/ng.3247","article-title":"Large-scale whole-genome sequencing of the Icelandic population","volume":"47","author":"Gudbjartsson","year":"2015","journal-title":"Nat Genet"},{"key":"2026051101314596000_ref51","doi-asserted-by":"publisher","first-page":"e1608","DOI":"10.1210\/clinem\/dgad734","article-title":"Obesity variants in the GIPR gene do not associate with risk of fracture or bone mineral density","volume":"109","author":"Styrkarsdottir","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026051101314596000_ref52","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/ije\/dyaa157","article-title":"Data resource profile: the Copenhagen hospital biobank (CHB)","volume":"50","author":"S\u00f8rensen","year":"2021","journal-title":"Int J Epidemiol"},{"key":"2026051101314596000_ref53","doi-asserted-by":"publisher","first-page":"e028401","DOI":"10.1136\/bmjopen-2018-028401","article-title":"DBDS genomic cohort, a prospective and comprehensive resource for integrative and temporal analysis of genetic, environmental and lifestyle factors affecting health of blood donors","volume":"9","author":"Hansen","year":"2019","journal-title":"BMJ Open"},{"key":"2026051101314596000_ref54","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1423-0410.2011.01553.x","article-title":"The Danish blood donor study: a large, prospective cohort and biobank for medical research","volume":"102","author":"Pedersen","year":"2012","journal-title":"Vox Sang"},{"key":"2026051101314596000_ref55","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"2026051101314596000_ref56","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"2026051101314596000_ref57","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"key":"2026051101314596000_ref58","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","article-title":"Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes","volume":"50","author":"Malik","year":"2018","journal-title":"Nat Genet"},{"key":"2026051101314596000_ref59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ajhg.2017.12.005","article-title":"Life-course genome-wide association study meta-analysis of Total body BMD and assessment of age-specific effects","volume":"102","author":"Medina-Gomez","year":"2018","journal-title":"Am J Hum Genet"},{"key":"2026051101314596000_ref60","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ije\/dyt179","article-title":"Calculating statistical power in mendelian randomization studies","volume":"42","author":"Brion","year":"2013","journal-title":"Int J Epidemiol"},{"key":"2026051101314596000_ref61","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/35\/2\/ddaf177\/65666038\/ddaf177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/35\/2\/ddaf177\/65666038\/ddaf177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:31:56Z","timestamp":1778477516000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/doi\/10.1093\/hmg\/ddaf177\/8362149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,9]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddaf177","relation":{},"ISSN":["1460-2083"],"issn-type":[{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2025,12,1]]},"article-number":"ddaf177"}}